Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
Strategies and innovations related to how clinical professionals are utilizing technology internal and external to their organizations to advance clinical trials. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
Clinical Conductor CTMS’s parent company, Bio-Optronics, Inc., and the Society of Clinical Research Sites (SCRS) have collaborated to expand and advance the knowledge of clinical trial site management challenges and opportunities. Through this relationship, Clinical Conductor CTMS and the SCRS have identified critical metrics with the aim of establishing industry benchmarks for clinical research sites.
“SCRS is committed to supporting the success of the global clinical site community. Reliable data and metrics provide sites and industry stakeholders with information that will help shape the site landscape,” says Christine Pierre, President of SCRS. “The collaboration with Clinical Conductor CTMS during these early stages has been instrumental in helping us achieve this goal. Their willingness to collaborate with SCRS and to build SCRS’ Site Metrics Platform to allow all sites to contribute their data moving forward is a testimonial to the collaborative efforts SCRS values.”
Clinical Conductor CTMS has provided the SCRS with de-identified, non-patient information from sites who have agreed to participate. Site metrics provided from Clinical Conductor CTMS will assist SCRS to establish site metrics and cycle times for a number of clinical trial parameters. This information includes study startup cycle time, patient enrollment metrics, budgetary and contract statistics and other analytics.
“The advancement of clinical trial management and research operations is one of the guiding principles behind Clinical Conductor CTMS,” explains Dan Kerpelman, CEO of Bio-Optronics. “Working with the SCRS to establish actionable metrics for the benefit of all researchers was a natural initiative for our organization. We take pride in our ability to participate in this noteworthy and beneficial venture.”
The SCRS and Clinical Conductor CTMS collaboration is intended to be an ongoing endeavor and will continue to expand and enhance the industry benchmark initiative that is being established. The initial results include Clinical Conductor CTMS sites that have chosen to participate in this endeavor. However, the SCRS benchmarking engine, built by Clinical Conductor CTMS, has been designed to allow research sites using other CTMS applications to include their data and benefit from future benchmarking reports. The initial results of this collaboration will be unveiled during the “Benchmarking Your Site” session at the Site Solutions Summit in Amelia Island, FL on October 12, 2013.